http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2640793-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26e19c12ac350fc1c0c02bcf301685e6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-10063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-10022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-10034 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate | 2007-02-09^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-11-24^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c7616558f582bfe185f52409f66bc29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9348202a2d3cb40bae6eac4ceab5f3c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_073b67ad1dca6accc650db7b7e6282b9 |
| publicationDate | 2015-11-24^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2640793-C |
| titleOfInvention | Peptide domain required for interaction between the envelope of a virus pertaining to the herv-w interference group and an hasct receptor |
| abstract | The present invention relates to a peptide domain necessary for the interaction between the envelope of a virus belonging to the interference group of HERV-W and a hASCT receptor, comprising an N-terminal end and a C-terminal end, said peptide domain being delimited: at its N terminal end, by a motif, consisting of the amino acids (Z).alpha.-Proline-Cysteine-X-Cysteine in which Z is any amino acid .alpha. is an integer between 2 and 30 X is any amino acid, at its C terminal end, by a motif, consisting of the amino acids Serine-Aspartic Acid-Xa-Xb-Xc-Xd-Xe-Aspartic Acid-Xf Xg-(Z).beta. wherein Xa, Xb, Xc, Xd, Xe, Xf Xg are any amino acids Z is any amino acid .beta. is an integer between 15 and 25, preferably 20 and comprising, between the N terminal end and the C terminal end, at least one unit chosen from the following units; a unit consisting of the amino acids Cysteine-Tyrosine-X2-X3-X4-X5-X6-Cysteine, in which X2, X3, X4, X5, X6 are any amino acids a unit consisting of the amino acids Cysteine-X7- X8-X9-X10-X11-X12-X13-X14-X15-Cysteine-Trytophan, wherein X7, X8, X9, X10, X11, X12, X13, X14, X15 are any amino acids |
| priorityDate | 2006-02-09^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 237 of 237.